The Latest Breaking News from FDA

The US Supreme Court has ruled on a challenge to mifepristone pills, the most common method in the US, which was brought by anti-abortion campaigners in the first abortion controversy since Roe v. Wade

The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

The ruling comes less than a year after the justices overturned Roe v. Wade.

The court’s decision maintains access to a widely used abortion drug for millions of Americans, for now

The ruling preserves broad access to mifepristone, while litigation continues over the pill’s approval for US use.

The Supreme Court weighs in on a case involving a drug commonly used for abortions that the FDA first approved in 2000.

The US Supreme Court is considering whether to uphold restrictions to the pill used in more than half of US abortions.

The US Supreme Court has ruled on a challenge to mifepristone pills, the most common method in the US, which was brought by anti-abortion campaigners in the first abortion controversy to reach the nation's highest court since its conservative majority overturned Roe v. Wade

Head of senior civil servants union rejects claims ex-justice secretary was victim of Whitehall plot

Social media users shared a range of false claims this week